Results. Implementation of universal decolonization was completed within 6 months. The estimated rate of CLABSI decreased by 23.5% (95% confidence interval, 9.8%-35.1%; P = .001). There was no evidence of a trend over time in either the pre-or postimplementation period. Adjusting for seasonality and number of beds did not materially affect these results.
Conclusions. Dissemination of universal decolonization of ICU patients was accomplished quickly in a large community health system and was associated with declines in CLABSI consistent with published clinical trial findings.
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There has been increasing interest in improving the dissemination of best practices into routine clinical care. Despite frequent acknowledgment of the need for faster translation of evidence-based interventions into practice, it can be challenging to accomplish this. This is often the case even when the desired interventions are the product of pragmatic trials that are intended to test interventions under conditions of routine practice [1, 2] . Growing evidence suggests that universal decolonization of intensive care unit (ICU) patients reduces the risk of healthcare-associated bloodstream infections (BSIs). These include central line-associated bloodstream infections (CLABSIs), which comprise the majority of these infections [3] . In 2009, an estimated 18 000 CLABSIs occurred among patients hospitalized in ICUs in the United States, down from 43 000 in 2001 [4] . However, despite recent reductions in the incidence of CLABSIs, they continue to result in increased length of stay and costs, as well as significant mortality. Klevens et al reported that up to 25% patients who develop a CLABSI in the ICU will die [5] .
A 43-hospital pragmatic trial (the REDUCE MRSA trial) found that universal decolonization of patients in the ICU with a combination of chlorhexidine (CHG) bathing and intra-nasal mupirocin significantly reduced methicillin-resistant Staphylococcus aureus (MRSA)-positive clinical cultures by 37% and BSIs from any pathogen by 44% [6] . However, the broad adoption of universal decolonization into routine practice has not been demonstrated to achieve com-parable gains. This study's goal was to determine whether the clinical trial procedures could be effectively translated into routine practice and whether doing so would yield the same clinical benefit. To address this question, we tested a prerelease version of a now publicly available universal decolonization toolkit offered by the Agency for Healthcare Quality and Research [7] for its utility in implementation of routine universal decolonization of ICU patients and its impact on catheter-related BSIs. The ability to rapidly implement universal decolonization would show the advantage of a well-designed toolkit and associated resources in combination with a supportive implementation plan; accompanying decreases in CLABSIs would support the previously demonstrated benefit of universal decolonization.
METHODS

Setting
This study was conducted in 136 ICUs in 95 acute care hospitals affiliated with the Hospital Corporation of America (HCA) healthcare system. Facilities were distributed across the United States, representing urban and suburban communities in 17 states. From geographic, demographic, and socioeconomic standpoints, this population is representative of the US population as a whole [8] .
Census and administrative data were obtained from corporate data warehouses, which undergo line-item validation until 99% accuracy is achieved. Primary analysis was reduction in health-care-associated CLABSIs using National Healthcare Safety Network (NHSN) surveillance definitions [9] as reported by hospital-based infection preventionists as part of routine surveillance responsibilities. ICU patient-days from NHSN data were matched with administrative data within 10% threshold to verify patient demographics. Implementation A recommended policy and procedure of universal decolonization for all ICU patients, based on the results of the REDUCE MRSA trial [6] , was introduced in January 2013; this practice was implemented in all participating facilities by June 2013. Implementation procedures followed previously published methods outlined in the Universal ICU Decolonization Toolkit, which provides instruction for implementing universal decolonization in adult ICUs [7] . In short, all patients received twice-daily intranasal mupirocin for 5 days or the length of their ICU stay, whichever was shorter, and were bathed daily with CHG-impregnated cloths for their entire ICU stay.
Key stakeholders for implementation included leadership champions, healthcare providers, infection preventionists, pharmacists, and information technology and supply chain personnel. Planning and deployment tactics were coordinated by corporate infection prevention personnel using available toolkit resources, operational and process measures from electronic health record systems providing aggregate and standardized data, and coaching calls. The toolkit contains detailed implementation guidance and materials, including a flowchart, a guide to assessing readiness, messages for healthcare workers, a detailed decolonization protocol and training materials, a skills assessment guide, and safety information. The toolkit used in this study was identical to the publicly available toolkit [7] used in the REDUCE MRSA trial [6] .
Implementation tactics included enterprise coaching calls focused on evidence rationale, preparation, implementation, and tactics to achieve highly compliant practices; Table 1 outlines the coaching call strategy and schedule. Coaching calls 1-4 occurred within the first 3 months of the implementation period, and coaching call 5 occurred later within that time period. Through these coaching calls, the enterprise team facilitated and informally verified implementation as well as gathered feedback and gauged the readiness for implementation at the local level. Related resources and audio podcasts were available through a central corporate intranet site. Questions were directed to corporate email for response and incorporated into frequently asked questions that were provided to all facilities for their reference. Physician-specific communication resources and evidence tools to support endorsement were available as well as an enterprise physician study investigator to directly address peer concerns.
Statistical Analysis
The preimplementation period was defined as January 2011 through December 2012. The postimplementation period was defined as July 2013 through February 2014. The phase-in period, January through June 2013, was omitted from analysis. The 43 hospitals (74 ICUs) in the original trial were excluded from the analysis, as were facilities without separate critical care units. In addition, facilities missing data for an entire portion of the study period due to unit closure, opening, or entry into the HCA system were omitted. Of the 122 HCA-affiliated hospitals that were not in the original trial, 27 were excluded from the final analysis, resulting in 95 participating hospitals. We used a Poisson generalized linear mixed-model regression analysis for CLABSI events to assess differences between the pre-and postimplementation periods while accounting for hospital-and unit-level correlation. Unadjusted and adjusted analyses were conducted with the log number of central lines per unit as the offset adjustment. The adjusted analysis included season, number of unit beds, and unit type. The possibility of trend over time was assessed. To compare the standard infection ratio (SIR) in the pre-and postimplementation periods, we repeated the Poisson analysis described above, but used the Centers for Disease Control and Prevention (CDC) expected number of CLABSIs as the offset, rather than the log line-days. Analyses were performed using SAS software, version 9.4 (SAS Institute, Cary, North Carolina).
This study was approved by the Harvard Pilgrim Health Care Institutional Review Board. based on NHSN population reporting criteria [10] . Patient characteristics were similar between the baseline and postintervention periods ( Table 2) .
RESULTS
During implementation, uptake of the various toolkit components was informally assessed through the enterprise coaching calls (Table 1) and questions submitted to the corporate team. Challenges identified via this process included (1) concerns about mupirocin resistance and (2) questions about peer review of the original trial results, which was accepted for publication during the implementation period. These challenges were addressed via peer-to-peer conversations from physician champions and the corporate implementation team. In contrast, most facilities were able to easily implement daily CHG bathing, as this practice, when supported by education about appropriate methods, fit within the normal nursing workflow and did not require a physician order. There was no evidence of trend over time in either the pre-or postimplementation period. Adjusting for seasonality, number of beds, and unit type did not materially affect these results (rate decrease, 23.1% [95% CI, 8.8%-35.1%]; P = .003). In units classified as medical/surgical, which comprised 60.3% of all participated units, the rate of CLABSIs decreased 25.8% (95% CI, 9.6%-39.1%; P = .003); the number of other unit types was too small to stratify the analysis by those unit types.
We observed a reduction for all pathogen types, with the largest impact on gram-positive pathogens (Figure 2 ), similar to our original study [6] . The gram-positive CLABSI rate decreased 28.7% (95% CI, 9.7%-43.7%; P = .005). The number of CLABSI events due to other organisms was too small to stratify the analysis by other pathogen types, including Staphylococcus aureus. The rate of CLABSI due to S. aureus decreased from 0.11 per 1000 central line-days to 0.02 per 1000 central line-days, a de-crease of 31.9% (95% CI, 27.2%-63.5%; P = .2); there were 66 CLABSIs due to S. aureus in the preintervention period and 12 in the postintervention period.
After implementation, the mean SIR decreased 21.5% (95% CI, 7.5%-33.5%; P = .004). The mean SIR preimplementation was 0.66 (95% CI, .61-.71); the mean SIR postimplementation was 0.51 (95% CI, .44-.59).
We examined small multiples as a way of assessing heterogeneity between units. This has revealed that some units began the baseline period with very low rates of CLABSI and others with relatively variable rates. Postintervention, rates were uniformly low (Supplementary Appendices 1 and 2).
DISCUSSION
This rapid dissemination and implementation program demonstrated the utility of a protocol-specific toolkit, coupled with a multistep translation program to implement universal decolonization in a large, complex organization. Doing so demonstrated that use of CHG bathing plus nasal mupirocin in routine practice reduced ICU CLABSIs at a level commensurate with that achieved within the framework of a clinical trial. This supports the use of universal decolonization in a wide variety of acute care facilities across the United States.
The speed at which this study was accomplished highlights several possible contributing factors that may influence the success of implementations. These include (1) a well-designed tool-kit with proven success in a pragmatic clinical trial; (2) a program team, experienced in implementing evidence-based practices, that is responsive to local needs; and (3) an established infrastructure for implementing large quality improvement projects. As this study showed, when these factors are used to implement an evidence-based practice, widespread improvements can be achieved.
Investigation into which evidence-based practices are the safest, most effective, and most efficient for patients, and the subsequent implementation of these results, forms the foundation for building a learning health system. In such a system, research is integrated into routine care to generate clinical evidence. This strategy not only addresses current challenges in healthcare but also complements patient care activities, thereby maximizing the potential to improve safety, effectiveness, and value through-out the entire system [11] . By creating standardized support and encouraging local adaptation and collaboration, this study facilitated the rapid integration of new evidence into routine care. This reduction in BSIs agrees with previously published trials using CHG with or without mupirocin. In 2007, Bleasdale and colleagues performed a 52-week, 2-arm, crossover trial to deter-mine whether patients bathed with CHG cloths had a lower incidence of primary BSIs compared with patients bathed with soap and water in a medical ICU setting. In 2 geographically separate but similar 11-bed units, patients in the CHG intervention arm were significantly less likely to acquire a primary BSI (4.1 vs 10.4 infections per 1000 patient-days) [12] . In 2012, Montecalvo and associates published a prospective, 3-phase multiple-hospital study in which the intervention progressed from bathing with soap and water or nonmedicated cloths to bathing with 2% CHG cloths to continued CHG bathing without oversight by re-search personnel. Compared with preintervention, CHG bathing was associated with significant reductions in CLABSIs from 6.4 per 1000 catheter-days to 2.6 per 1000 catheter-days (P < .001) [13] . Climo et al performed a nonblinded cluster-randomized crossover study on the incidence of hospital-acquired BSIs and found a 28% reduction in the overall rate of hospital-acquired BSIs with CHG bathing vs nonmedicated cloths [14] . Using a similar study design, Milstone et al reported that CHG bathing was associated with a significant reduction in BSIs among pediatric ICU patients compared with standard bathing [15] . The study on REDUCE MRSA trial [6] , found that universal decolonization of all ICU patients with CHG bathing and intranasal mupirocin was associated with a statistically significant 44% reduction in all-pathogen BSIs [6] . These studies support the recently published recommendation that ICU patients >2 months of age should be bathed with CHG on a daily basis to prevent CLABSIs [16] .
These studies and the current one also underscore the fact that events like CLABSI are simultaneously common enough to rep-resent an important national cause of preventable morbidity and mortality, yet too rare for most individual hospitals to be able to measure the benefit of a practice that substantially reduces the at-tack rate. This phenomenon is illustrated by a recent single center trial by Noto et al, which did not have sufficient power to identify an effect of universal decolonization on CLABSI, as there were only 4 events in the nonintervention period [17] .
Although demonstrating the benefit of this toolkit and associated implementation program in actual practice required observation in a large set of ICUs, we believe the results should be generalizable to most hospitals. The rates of CLABSIs, a nation-ally reported measure, were assessed using CDC criteria. These facilities had already implemented national, evidencebased recommendations for preventing healthcare-associated CLABSI and achieved rates at or below national rates. The toolkit used in this study had been designed to work within usual hospital processes and to be applicable to a wide range of facilities; the ability to incorporate these practices into existing workflows also contributes to the generalizability of the results.
This study also illustrates how providers across the United States can transform themselves into a learning health system by leveraging reproducible methods for introducing new evidence into routine practice [18] . The use of a toolkit containing an array of documentation and educational materials should produce replicable results in most hospitals. Coaching calls to share evidence and experience supporting the intervention as well as to engage and motivate key local stakeholders to take ownership proved highly effective, even for physically distant facilities. Our study contained the proposed 5 key components for effective knowledge translation: (1) a focus on systems rather than care of individual patients; (2) engagement of local inter-disciplinary teams to assume ownership of the improvement project; (3) creation of centralized support for the technical work; (4) encouraging local adaption of the intervention; and (5) creating a collaborative culture within the local unit and larger system [2] .
Our study has some limitations. First, the study results may not be generalizable to hospitals without strong infrastructures for quality improvement. In this study, we benefited from our system's experience with large-scale implementations as well as our familiarity with the intervention itself. Second, our study lacks the rigorous compliance assessments of the original trial; however, the intent was to reflect true life posttrial pragmatic implementation across a broad number of hospitals. Last, although the corporate team was not aware of any new interventions introduced during the implementation phase, this was not tracked as carefully as in the original trial.
The investigation of possible development of mupirocin and CHG resistance was a planned secondary analysis of the REDUCE MRSA trial [6] . While monitoring resistance is outside the scope of the current study, further research has been conducted to investigate possible resistance and identify other agents that could be used while maintaining the infrastructure that allowed for the rapid implementation of this program.
CONCLUSIONS
We used publicly available materials and standard methods for translation to effect rapid dissemination of universal decolonization of patients in adult ICUs. This resulted in rapid reduction in the rate of CLABSIs throughout a large community health-care system. This benefit was observed in the context of rates already reduced through the use of other widely used prevention methods. The implementation plan engaged healthcare system clinicians, senior management, and staff to achieve a translation of new evidence into accelerated improvement, and is broadly applicable.
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